Clinical Outcomes and Treatments for Pulmonary Embolism A Study by the Bern Acute Pulmonary Embolism Registry

What this Trial Is About

Researchers are collecting data to study the safety and effectiveness of treatments for patients with pulmonary embolism PE. This study focuses on treatments decided by a multi-disciplinary pulmonary embolism response team PERT and aims to improve treatment decisions, hospital procedures, and methods for PE care. It includes both past patients and those treated after May 2020. The study gathers information on various advanced treatments such as systemic thrombolysis, catheter-directed thrombolysis, and surgical removal of blood clots embolectomy. It includes retrospective data from patients treated between 2001 and April 2020 and prospective data from patients treated after May 2020. The study records treatments and health outcomes related to acute and chronic PE. Participants will have their medical treatments and results reviewed, including any complications during procedures and any recurrence of blood clots up to five years later. Respiratory function and the development of chronic lung-related high blood pressure will also be monitored. The main outcome measured is death occurring within 30 days in the hospital. Participants are followed over time to understand long-term effects and safety.

Clinical Outcomes After Acute Pulmonary Embolism